136 related articles for article (PubMed ID: 27055850)
1. Stereotactic Radiofrequency Ablation for Metastatic Melanoma to the Liver.
Bale R; Schullian P; Schmuth M; Widmann G; Jaschke W; Weinlich G
Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1128-35. PubMed ID: 27055850
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Scharll Y; Ianetti-Hackl C; Bale R
Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1184-1193. PubMed ID: 33825059
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.
Bale R; Widmann G; Schullian P; Haidu M; Pall G; Klaus A; Weiss H; Biebl M; Margreiter R
Eur Radiol; 2012 Apr; 22(4):930-7. PubMed ID: 22071776
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
[TBL] [Abstract][Full Text] [Related]
5. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Widmann G; Schullian P; Haidu M; Bale R
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Radiofrequency Ablation for Breast Cancer Liver Metastases.
Bale R; Richter M; Dünser M; Levy E; Buchberger W; Schullian P
J Vasc Interv Radiol; 2018 Feb; 29(2):262-267. PubMed ID: 29273283
[TBL] [Abstract][Full Text] [Related]
9. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma.
Mariani P; Almubarak MM; Kollen M; Wagner M; Plancher C; Audollent R; Piperno-Neumann S; Cassoux N; Servois V
Eur J Surg Oncol; 2016 May; 42(5):706-12. PubMed ID: 26968227
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study.
Haidu M; Dobrozemsky G; Schullian P; Widmann G; Klaus A; Weiss H; Margreiter R; Bale R
Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1074-82. PubMed ID: 22006031
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
[No Abstract] [Full Text] [Related]
13. Liver resection and ablation for metastatic melanoma: A single center experience.
Doussot A; Nardin C; Takaki H; Litchman TD; D'Angelica MI; Jarnagin WR; Postow MA; Erinjeri JP; Kingham TP
J Surg Oncol; 2015 Jun; 111(8):962-8. PubMed ID: 26073980
[TBL] [Abstract][Full Text] [Related]
14. Short- and-long term results of intraoperative radiofrequency ablation of liver metastases.
Navarra G; Ayav A; Weber JC; Jensen SL; Smadga C; Nicholls JP; Habib NA; Jiao LR
Int J Colorectal Dis; 2005 Nov; 20(6):521-8. PubMed ID: 15864606
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic liver packing to protect surrounding organs during thermal ablation.
Schullian P; Weiss H; Klaus A; Widmann G; Kranewitter C; Mittermair C; Margreiter R; Bale R
Minim Invasive Ther Allied Technol; 2014 Oct; 23(5):294-301. PubMed ID: 24641527
[TBL] [Abstract][Full Text] [Related]
16. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
Schullian P; Putzer D; Laimer G; Levy E; Bale R
Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
19. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
Lorentzen T; Skjoldbye BO; Nolsoe CP
Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiofrequency ablation of a variety of liver masses in children.
Hetzer B; Vogel GF; Entenmann A; Heil M; Schullian P; Putzer D; Meister B; Crazzolara R; Kropshofer G; Salvador C; Straub S; Karall D; Niederwanger C; Cortina G; Janecke A; Freund-Unsinn K; Maurer K; Schweigmann G; Oberhuber G; Renz O; Schneeberger S; Müller T; Bale R
Int J Hyperthermia; 2020; 37(1):1074-1081. PubMed ID: 32954876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]